Table 1.

Median time to first infection for Cmaxss quartiles.

Exposure QuartileCmaxss Range, μg/mLaTime to First Infection, Days, Median (95% CI)Log-rank P
Pooled SC and IV, 2–17 yrs
    Q1[19.1–49.7]244 (129–462)0.45
    Q2(49.7–65.8]152 (106–216)
    Q3(65.8–198.0]162 (91–246)
    Q4(198.0–307.0]186 (82–224)
SC, 2–5 yrs
    Q1[37.7–54.4]77 (10–511)0.93
    Q2(54.4–61.1]77 (27–439)
    Q3(61.1–69.2]87 (36–200)
    Q4(69.2–119.0]67 (25–245)
SC, 6–17 yrs
    Q1[19.1–42.4]430 (156–577)0.48
    Q2(42.4–52.8]108 (63–291)
    Q3(52.8–62.5]204 (113–466)
    Q4(62.5–101.0]266 (152–448)
IV, 6–17 yrs
    Q1[119.0–192.5]188 (91–473)0.50
    Q2(192.5–214.5]76 (51–211)
    Q3(214.5–238.5]186 (49–684)
    Q4(238.5–307.0]192 (81–224)
  • Q1 and Q4 represent the lowest and the highest quartile, respectively.

  • a For PK ranges, a square bracket indicates respective endpoint is included in the interval. A round bracket indicates respective endpoint is not included in the interval. Cmaxss: steady-state maximum serum concentration; IV: intravenous; PK: pharmacokinetic; Q: quartile; SC; subcutaneous.